Laurence MILLON

Laboratoire de Parasitologie-Mycologie, Plateau de Microbiologie, Niveau +3, Batiment PC Bio, CHU Jean Minjoz, Bd Fleming, 25000 Besançon

Laurence Millon

Professor
PATHOGENES

lmillon@-Code to remove to avoid SPAM-chu-besancon.fr
+33 370 63 23 53

Molecular biology, immunology, epidemiology, diagnostics,
Invasive fungal infections, resistance, parasitic infections, echinococcosis, allergies, hypersensitivity pneumonitis

Head of the Parasitology-Mycology Laboratory, Besançon University Hospital (since 2008)
Head of the National Echinococcosis Reference Centre (since 2012)
Coordinator of 9 national/international research projects over the last 10 years

Hospital work: diagnosis of fungal and parasitic infections, development of new techniques (biomarker for monitoring echinococcosis, molecular diagnosis of invasive fungal infections, development of recombinant antigens/serodiagnosis of hypersensitivity pneumonitis).
Research activity: molecular epidemiology, host-parasite interaction, antifungal resistance, microbiological environment and allergic respiratory pathologies

Current projects :

  • HIS QPCR ECHINO: High Sensitive DNA qPCR for Echinococcosis Diagnosis – Call for projects Innovation CHU Besançon- 2023-2025
  • BM-ASPICU: Non-invasive tools to better diagnose invasive aspergillosis infections in ICU patients with covid-19 and other non-immunosuppressive conditions – PFIZER Global Grant / CHU Besançon – 2022-2024
  • EMBRASE : Environnement Microbiologique et Risque Allergique, cohorte d’enfants de 5 ans (cohorte ELFE) – Agence Nationale de la Recherche (APP ANR 2017) 2018-2022
  • MODIMUCOR : Evaluation prospective d’un nouvel outil moléculaire pour le diagnostic précoce de la mucormycose – PHRC national (Ministère de la Santé) 2014-2022

 

Project submitted :

  • GAP-AFR : Bridging the gap between environment and patient ; investigating the risk and transmission of antifungal resistance in Aspergillus fumigatus – proposition complete soumise en juin 2023 à l’appel d’offre JPIAMR-ACTION
  • Joint Programming Initiative on Antimicrobial Resistance
    PHRC AmbisaMucor: Optimized Liposomal Amphotericin B and Isavuconazole combination for Mucormycosis Treatment – Letter of intent submitted – October 2023

https://www.researchgate.net/profile/Laurence_Millon